Inactive Instrument

Press Releases Icosavax, Inc.

Equities

ICVX

US45114M1099

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

AstraZeneca - Acquisition of Icosavax Completed	Feb. 20	AQ
Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law Firm	Feb. 01	PR
ICVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to Shareholders	Jan. 03	BU
ICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVX	Dec. 29	BU
Levi & Korsinsky, LLP Notifies Investors of an Investigation into Icosavax Inc.	Dec. 19	PR
ICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVX	Dec. 14	BU
SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Icosavax; Is the Deal in the Best Interest of Shareholders?	Dec. 13	BU
Oracle, Hasbro fall; Icosavax, Perion Network rise, Tuesday, 12/12/2023	Dec. 12	AQ
Shareholder Alert: Ademi LLP investigates whether Icosavax, Inc. has obtained a Fair Price in its transaction with AstraZeneca	Dec. 12	PR
ICVX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to Shareholders	Dec. 12	BU
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca	Dec. 12	AQ
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults	Dec. 12	AQ
Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 14	AQ
Icosavax to Participate in the Jefferies London Healthcare Conference	Nov. 08	AQ
Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference	23-10-31	AQ
Icosavax : October 2023 Corporate Presentation	23-10-16	PU
Icosavax : September 2023 Corporate Presentation	23-09-22	PU
Icosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023	23-09-19	AQ
Icosavax : Corporate Overview	23-08-29	PU
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Icosavax, Inc.

Equities

ICVX

US45114M1099

Press Releases

Filters